source
- FDA Approves T-DXd for Early-Stage HER2+ Breast CancerThe FDA approved trastuzumab deruxtecan for the adjuvant and neoadjuvant treatment of select early-stage HER2-positive breast cancer.onclive · 2mo ago↗ source
- Dr Garzotto on Aglatimagene Besadenovec Plus Valacyclovir and EBRT in Localized Prostate CancerMark Garzotto, MD, discusses efficacy data with aglatimagene besadenovec plus valacyclovir and EBRT in localized prostate cancer.onclive · 2mo ago↗ source
- Dr Cirstea on Sequencing Considerations in R/R Multiple MyelomaDiana Cirstea, MD, discusses sequencing considerations in relapsed/refractory multiple myeloma in the era of T-cell–redirecting therapies.onclive · 2mo ago↗ source